- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02345720
Effects of Multifocal Contact Lens on Ocular Tissue
June 18, 2018 updated by: Johnson & Johnson Vision Care, Inc.
Effects on Ocular Tissues of Vistakon® Investigational Multifocal Contact Lenses - Asian Population Study
The purpose of this study is to evaluate the etafilcon - PVP (multi-focal)
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
London, United Kingdom, SW1E6AU
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The subject must read, understand, and sign the statement of Informed Consent and receive a fully executed copy of the form.
- The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
- The subject must be between 40 and 70 years of age.
- The subject's vertex corrected spherical equivalent distance refraction must be in the range of 1.00 too -5.75 in each eye.
- The subject must identify themselves as Asian by self-report and have eyes and eyelids with an automatically Asian appearance.
- The subject's refractive cylinder must be less than or equal to -0.75D in each eye.
- The subject's ADD power must be in the range of +0.75 D to +2.5 D in each eye.
- The subject must have best corrected visual acuity of 20/20-3 or better in each eye.
- Subjects own a wearable pair of spectacles, if required for their distance vision.
- The subject must be an adapted soft contact lens wearer in both eyes (i.e. worn lenses a minimum of 5 days per week for at least 8 hours per day, for one month or more duration).
- The subject must already be wearing a presbyopic contact lens correction (e.g. reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or if not respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire".
Exclusion Criteria:
- Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued)
- Any ocular or systemic allergies that contraindicate contact lens wear.
- Any ocular or systemic disease, autoimmune disease, or use of medication, that will contraindicate contact lens wear.
- Any ocular abnormality that may interfere with contact lens wear.
- Use of any ocular medications, with the exception of rewetting drops.
- Any previous intraocular surgery (e.g. radial keratotomy, PRK, LASIK, etc.).
- Any grade 3 or greater slit lamp findings (e.g. edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) which may contraindicate contact lens wear.
- History of herpetic keratitis.
- Any ocular infection or inflammation.
- Any corneal distortion or irregular cornea.
- History of binocular vision abnormality or strabismus.
- Any infectious disease (e.g. hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g. HIV).
- History of diabetes.
- Habitual wearer of etafilcon-A contact lens material.
- Participation in any contact lens or lens care product clinical trial within 30 days prior to study enrollment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: etafilcon - PVP (multi-focal)
The investigational soft contact lenses will be worn in a daily wear modality for 30 days over the course of the study.
|
The investigational contact lens must be worn at least six hours daily.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Upper Eye Lid Margin Staining
Time Frame: 30 days Post wear
|
Upper Eye Lid Margin Staining is assessed via Ocular Photography using proprietary algorithm.
The average grade across upper eye lid margin was reported in mm^2.
|
30 days Post wear
|
|
Limbal Staining
Time Frame: 30 Days Post Wear
|
Measured via Ocular Photography using proprietary algorithm.
The limbal conjunctival lissamine green staining average surface area in % of the overall limbal area was reported.
|
30 Days Post Wear
|
|
Corneal Staining
Time Frame: 30 Days Post Wear
|
The corneal fluorescein staining average surface area in % of the upper corneal quadrant was reported.
|
30 Days Post Wear
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2014
Primary Completion (Actual)
May 1, 2015
Study Completion (Actual)
May 1, 2015
Study Registration Dates
First Submitted
January 19, 2015
First Submitted That Met QC Criteria
January 23, 2015
First Posted (Estimate)
January 26, 2015
Study Record Updates
Last Update Posted (Actual)
June 19, 2018
Last Update Submitted That Met QC Criteria
June 18, 2018
Last Verified
October 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- CR-5632
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Visual Acuity
-
Mayo ClinicNot yet recruitingVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Alcon ResearchQueensland University of TechnologyCompleted
-
Alcon ResearchCompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedVisual AcuityUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
Clinical Trials on etafilcon - PVP (multi-focal)
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive AmetropiaUnited States
-
Johnson & Johnson Vision Care, Inc.CompletedRefractive AmetropiaUnited States
-
Minia UniversityRecruitingRhegmatogenous Retinal DetachmentEgypt
-
Bausch & Lomb IncorporatedCompletedVision DisordersUnited States
-
Johnson & Johnson Vision Care, Inc.Completed
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
Shanghai Eye Disease Prevention and Treatment CenterShanghai General Hospital, Shanghai Jiao Tong University School of Medicine; Shandong University of Traditional Chinese MedicineNot yet recruiting